arginyl-glycyl-aspartic acid has been researched along with Cancer of Nasopharynx in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, J; Sheng, W; Wang, Y; Xie, Y; Yang, J | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Cancer of Nasopharynx
Article | Year |
---|---|
Adenovirus-mediated ING4/PTEN double tumor suppressor gene co-transfer modified by RGD enhances antitumor activity in human nasopharyngeal carcinoma cells.
Topics: Adenoviridae; Animals; Carcinoma; Cell Cycle Proteins; Cells, Cultured; Gene Transfer Techniques; Genes, Tumor Suppressor; Genetic Therapy; Genetic Vectors; Homeodomain Proteins; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oligopeptides; PTEN Phosphohydrolase; Transgenes; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2015 |